Statement of Changes in Beneficial Ownership (4)
07 September 2016 - 4:41AM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
MARTIN JOHN C
|
2. Issuer Name
and
Ticker or Trading Symbol
GILEAD SCIENCES INC
[
GILD
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__
X
__ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
Executive Chairman
|
(Last)
(First)
(Middle)
GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
9/1/2016
|
(Street)
FOSTER CITY, CA 94404
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
8/5/2016
|
|
J
|
V
|
731917
(1)
|
A
|
$0
|
731917
|
I
|
By Trust
|
Common Stock
|
8/5/2016
|
|
G
|
V
|
731917
(1)
|
D
|
$0
|
3287810
|
D
|
|
Common Stock
|
8/30/2016
|
|
G
|
V
|
156714
(2)
|
D
|
$0
|
3131096
|
D
|
|
Common Stock
|
9/1/2016
|
|
M
|
|
100000
|
A
|
$16.395
|
3231096
|
D
|
|
Common Stock
|
9/1/2016
|
|
S
|
|
95600
|
D
|
$77.451
(3)
|
3135496
|
D
|
|
Common Stock
|
9/1/2016
|
|
S
|
|
4400
|
D
|
$78.1926
(4)
|
3131096
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Non-qualified Stock Option (Right to Buy)
|
$16.395
|
9/1/2016
|
|
M
|
|
|
100000
|
(5)
|
1/22/2017
|
Common Stock
|
100000
|
$0
|
300000
|
D
|
|
Explanation of Responses:
|
(
1)
|
Shares gifted to family trust.
|
(
2)
|
Shares gifted to charitable trust
|
(
3)
|
Sale prices reported for the transactions reported here range from $77.06 to $78.03. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
|
(
4)
|
Sale prices reported for the transactions reported here range from $78.07 to $78.36. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
|
(
5)
|
The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
MARTIN JOHN C
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE
FOSTER CITY, CA 94404
|
X
|
|
Executive Chairman
|
|
Signatures
|
/s/ Marissa Song by Power of Attorney for John C. Martin
|
|
9/6/2016
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Sep 2024 to Oct 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Oct 2023 to Oct 2024